Cargando…

mTOR: A possible therapeutic target against SARS-CoV-2 infection

Detalles Bibliográficos
Autor principal: Khan, Nabab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225252/
https://www.ncbi.nlm.nih.gov/pubmed/34179893
_version_ 1783712054703554560
author Khan, Nabab
author_facet Khan, Nabab
author_sort Khan, Nabab
collection PubMed
description
format Online
Article
Text
id pubmed-8225252
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-82252522021-06-24 mTOR: A possible therapeutic target against SARS-CoV-2 infection Khan, Nabab Arch Stem Cell Ther Article 2021 /pmc/articles/PMC8225252/ /pubmed/34179893 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Khan, Nabab
mTOR: A possible therapeutic target against SARS-CoV-2 infection
title mTOR: A possible therapeutic target against SARS-CoV-2 infection
title_full mTOR: A possible therapeutic target against SARS-CoV-2 infection
title_fullStr mTOR: A possible therapeutic target against SARS-CoV-2 infection
title_full_unstemmed mTOR: A possible therapeutic target against SARS-CoV-2 infection
title_short mTOR: A possible therapeutic target against SARS-CoV-2 infection
title_sort mtor: a possible therapeutic target against sars-cov-2 infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225252/
https://www.ncbi.nlm.nih.gov/pubmed/34179893
work_keys_str_mv AT khannabab mtorapossibletherapeutictargetagainstsarscov2infection